SCHEMBL7077232

SCHEMBL7077232

CC(C)(C)OC(=O)ON1CCC(c2ccc(OCc3nc(-c4ccccc4Cl)no3)cc2)C(OCc2ccc3ccccc3c2)C1

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
REN P00797 13/20 0.50
FFAR1 O14842 2/20 0.46
ADORA2B P29275 1/20 0.38
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
GSTP1 P09211 1/20 0.35
SLC6A5 Q9Y345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7080048 0.92 REN (0.41) RENFFAR1ADORA2BCASP3SENP8
SCHEMBL7079998 0.91 REN (0.62) RENFFAR1CASP3SENP8SENP7
SCHEMBL7080785 0.89 REN (0.51) RENSLC6A5
SCHEMBL7080728 0.88 REN (0.49) RENFFAR1
SCHEMBL7078091 0.87 REN (0.64) RENFFAR1
SCHEMBL6041408 0.86 REN (0.56) RENFFAR1ADORA2BCASP3SENP8
SCHEMBL7075025 0.84 REN (0.52) REN
SCHEMBL7081341 0.83 REN (0.51) RENFFAR1
SCHEMBL6955011 0.83 REN (0.39) RENFFAR1ADORA2BCASP3SENP8
SCHEMBL7074891 0.82 REN (0.48) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed